180 related articles for article (PubMed ID: 25976094)
1. Differential involvement of IL-6 in the early and late phase of 1-methylnicotinamide (MNA) release in Concanavalin A-induced hepatitis.
Sternak M; Jakubowski A; Czarnowska E; Slominska EM; Smolenski RT; Szafarz M; Walczak M; Sitek B; Wojcik T; Jasztal A; Kaminski K; Chlopicki S
Int Immunopharmacol; 2015 Sep; 28(1):105-14. PubMed ID: 25976094
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse.
Sternak M; Khomich TI; Jakubowski A; Szafarz M; Szczepański W; Białas M; Stojak M; Szymura-Oleksiak J; Chłopicki S
Pharmacol Rep; 2010; 62(3):483-93. PubMed ID: 20631412
[TBL] [Abstract][Full Text] [Related]
3. 1-Methylnicotinamide protects against liver injury induced by concanavalin A via a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α.
Jakubowski A; Sternak M; Jablonski K; Ciszek-Lenda M; Marcinkiewicz J; Chlopicki S
Int Immunopharmacol; 2016 Feb; 31():98-104. PubMed ID: 26709075
[TBL] [Abstract][Full Text] [Related]
4. Single bout of endurance exercise increases NNMT activity in the liver and MNA concentration in plasma; the role of IL-6.
Chłopicki S; Kurdziel M; Sternak M; Szafarz M; Szymura-Oleksiak J; Kamiński K; Żołądź JA
Pharmacol Rep; 2012; 64(2):369-76. PubMed ID: 22661188
[TBL] [Abstract][Full Text] [Related]
5. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension.
Fedorowicz A; Mateuszuk Ł; Kopec G; Skórka T; Kutryb-Zając B; Zakrzewska A; Walczak M; Jakubowski A; Łomnicka M; Słomińska E; Chlopicki S
Respir Res; 2016 Aug; 17(1):108. PubMed ID: 27581040
[TBL] [Abstract][Full Text] [Related]
6. Activation of nicotinamide N-methyltrasferase and increased formation of 1-methylnicotinamide (MNA) in atherosclerosis.
Mateuszuk Ł; Khomich TI; Słomińska E; Gajda M; Wójcik L; Łomnicka M; Gwóźdź P; Chłopicki S
Pharmacol Rep; 2009; 61(1):76-85. PubMed ID: 19307695
[TBL] [Abstract][Full Text] [Related]
7. Favored T helper 1 response in a mouse model of hepatosteatosis is associated with enhanced T cell-mediated hepatitis.
Kremer M; Hines IN; Milton RJ; Wheeler MD
Hepatology; 2006 Jul; 44(1):216-27. PubMed ID: 16799967
[TBL] [Abstract][Full Text] [Related]
8. Murine concanavalin A-induced hepatitis is prevented by interleukin 12 (IL-12) antibody and exacerbated by exogenous IL-12 through an interferon-gamma-dependent mechanism.
Nicoletti F; Di Marco R; Zaccone P; Salvaggio A; Magro G; Bendtzen K; Meroni P
Hepatology; 2000 Oct; 32(4 Pt 1):728-33. PubMed ID: 11003616
[TBL] [Abstract][Full Text] [Related]
9. NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis.
Arshad MI; Rauch M; L'helgoualc'h A; Julia V; Leite-de-Moraes MC; Lucas-Clerc C; Piquet-Pellorce C; Samson M
Eur J Immunol; 2011 Aug; 41(8):2341-8. PubMed ID: 21557213
[TBL] [Abstract][Full Text] [Related]
10. Mice deficient in hepatocyte-specific IL-1Ra show delayed resolution of concanavalin A-induced hepatitis.
Lamacchia C; Rodriguez E; Palmer G; Vesin C; Seemayer CA; Rubbia-Brandt L; Gabay C
Eur J Immunol; 2012 May; 42(5):1294-303. PubMed ID: 22539301
[TBL] [Abstract][Full Text] [Related]
11. 1-Methylnicotinamide ameliorates lipotoxicity-induced oxidative stress and cell death in kidney proximal tubular cells.
Tanaka Y; Kume S; Araki H; Nakazawa J; Chin-Kanasaki M; Araki S; Nakagawa F; Koya D; Haneda M; Maegawa H; Uzu T
Free Radic Biol Med; 2015 Dec; 89():831-41. PubMed ID: 26482866
[TBL] [Abstract][Full Text] [Related]
12. Hepatoma-derived growth factor participates in concanavalin A-induced hepatitis.
Wang EM; Hu TH; Huang CC; Chang YC; Yang SM; Huang ST; Wu JC; Ma YL; Chan HH; Liu LF; Lu WB; Kung ML; Wen ZH; Wang JC; Ko CY; Tsai WL; Chu TH; Tai MH
FASEB J; 2020 Dec; 34(12):16163-16178. PubMed ID: 33063394
[TBL] [Abstract][Full Text] [Related]
13. Periplocoside A, a pregnane glycoside from Periploca sepium Bge, prevents concanavalin A-induced mice hepatitis through inhibiting NKT-derived inflammatory cytokine productions.
Wan J; Zhu YN; Feng JQ; Chen HJ; Zhang RJ; Ni J; Chen ZH; Hou LF; Liu QF; Zhang J; Yang L; Tang W; Yang YF; Nan FJ; Zhao WM; Zuo JP
Int Immunopharmacol; 2008 Sep; 8(9):1248-56. PubMed ID: 18602071
[TBL] [Abstract][Full Text] [Related]
14. CD36 deficiency attenuates immune-mediated hepatitis in mice by modulating the proapoptotic effects of CXC chemokine ligand 10.
Xu C; Zhang C; Ji J; Wang C; Yang J; Geng B; Zhao T; Zhou H; Mu X; Pan J; Hu S; Lv Y; Chen X; Wen H; You Q
Hepatology; 2018 May; 67(5):1943-1955. PubMed ID: 29220536
[TBL] [Abstract][Full Text] [Related]
15. The protective effect of intrasplenic transplantation of Ad-IL-18BP/IL-4 gene-modified fetal hepatocytes on ConA-induced hepatitis in mice.
Shao X; Qian Y; Xu C; Hong B; Xu W; Shen L; Jin C; Wu Z; Tong X; Yao H
PLoS One; 2013; 8(3):e58836. PubMed ID: 23516562
[TBL] [Abstract][Full Text] [Related]
16. Alleviation of fatty liver in a rat model by enhancing N
Takeuchi K; Yokouchi C; Goto H; Umehara K; Yamada H; Ishii Y
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):203-210. PubMed ID: 30446221
[TBL] [Abstract][Full Text] [Related]
17. Epigallocatechin-3-gallate (EGCG) attenuates concanavalin A-induced hepatic injury in mice.
Liu D; Zhang X; Jiang L; Guo Y; Zheng C
Acta Histochem; 2014 May; 116(4):654-62. PubMed ID: 24373695
[TBL] [Abstract][Full Text] [Related]
18. Phosphoinositide 3-kinase δ/γ inhibition does not prevent concanavalin A-induced hepatitis.
Liu Y; Xiong L; Chang Y; Tang J; Ang W; Yang T; Pi W; Yang X; Ye W; Luo Y; Wang Z
Mol Med Rep; 2013 Nov; 8(5):1305-10. PubMed ID: 23969545
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-39 exacerbates concanavalin A-induced liver injury.
Li Y; Gong L; Weng L; Pan X; Liu C; Li M
Immunopharmacol Immunotoxicol; 2021 Feb; 43(1):94-99. PubMed ID: 33412981
[TBL] [Abstract][Full Text] [Related]
20. Bimodal role of endogenous interleukin-6 in concanavalin A-induced hepatitis in mice.
Tagawa Y; Matthys P; Heremans H; Dillen C; Zaman Z; Iwakura Y; Billiau A
J Leukoc Biol; 2000 Jan; 67(1):90-6. PubMed ID: 10648002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
